Patients News | pharmaphorum

News

Next stage in GSK’s Zantac defense gets underway today

A hearing will get underway in Delaware later today in the latest phase of GSK’s attempts to defend itself from allegations that its Zantac drug caused cancer in patients.

News

NICE backs Pfizer’s Talzenna for advanced breast cancer

Pfizer’s PARP inhibitor Talzenna has become the first targeted treatment for HER2-negative locally advanced or metastatic breast cancer with BRCA1/2 mutations to be recomm

News

Professor Bola Owolabi, director of the National Healthcare Inequalities Improvement Programme at NHS England

Winners named in NHS healthcare inequality contest

A competition aimed at tackling unequal access to healthcare in the NHS has been won by C2-Ai, a company that has developed an artificial intelligence-based risk assessmen

News

Women’s health gap estimated at $1trn in new report

The disparity in access to healthcare between women and men around the world is often talked about, but has never been given a dollar value – until now.

News

Google chatbot tops docs on accuracy, bedside manner

An experimental medical chatbot based on a large language model (LLM) developed by Google has been shown to be more accurate than primary-care doctors in diagnosing some i

News

Vivek Ramaswamy exits presidential race after Iowa result

Biotech entrepreneur Vivek Ramaswamy’s campaign to become the Republican candidate for the US presidency in the 2024 election has been suspended after a disappointing resu

Next stage in GSK’s Zantac defense gets underway today

NICE backs Pfizer’s Talzenna for advanced breast cancer

Winners named in NHS healthcare inequality contest

Women’s health gap estimated at $1trn in new report

Google chatbot tops docs on accuracy, bedside manner

Vivek Ramaswamy exits presidential race after Iowa result

Ultragenyx to slash costs after Angelman trial failure

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks